24-Week beta-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy males
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SAUNDERS, Bryan | |
dc.contributor.author | FRANCHI, Mariana | |
dc.contributor.author | OLIVEIRA, Luana Farias de | |
dc.contributor.author | SILVA, Vinicius da Eira | |
dc.contributor.author | SILVA, Rafael Pires da | |
dc.contributor.author | PAINELLI, Vitor de Salles | |
dc.contributor.author | COSTA, Luiz Augusto Riani | |
dc.contributor.author | SALE, Craig | |
dc.contributor.author | HARRIS, Roger Charles | |
dc.contributor.author | ROSCHEL, Hamilton | |
dc.contributor.author | ARTIOLI, Guilherme Giannini | |
dc.contributor.author | GUALANO, Bruno | |
dc.date.accessioned | 2020-03-24T14:52:54Z | |
dc.date.available | 2020-03-24T14:52:54Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Purpose To investigate the effects of chronic beta-alanine (BA) supplementation on muscle taurine content, blood clinical markers and sensory side-effects. Methods Twenty-five healthy male participants (age 27 +/- 4 years, height 1.75 +/- 0.09 m, body mass 78.9 +/- 11.7 kg) were supplemented with 6.4 g day(-1) of sustained-release BA (N = 16; CarnoSyn (TM), NAI, USA) or placebo (PL; N = 9; maltodextrin) for 24 weeks. Resting muscle biopsies of the m. vastus lateralis were taken at 0, 12 and 24 weeks and analysed for taurine content (BA, N = 12; PL, N = 6) using high-performance liquid chromatography. Resting venous blood samples were taken every 4 weeks and analysed for markers of renal, hepatic and muscle function (BA, N = 15; PL, N = 8; aspartate transaminase; alanine aminotransferase; alkaline phosphatase; lactate dehydrogenase; albumin; globulin; creatinine; estimated glomerular filtration rate and creatine kinase). Results There was a significant main effect of group (p = 0.04) on muscle taurine, with overall lower values in PL, although there was no main effect of time or interaction effect (both p > 0.05) and no differences between specific timepoints (week 0, BA: 33.67 +/- 8.18 mmol kg(-1) dm, PL: 27.75 +/- 4.86 mmol kg(-1) dm; week 12, BA: 35.93 +/- 8.79 mmol kg(-1) dm, PL: 27.67 +/- 4.75 mmol kg(-1) dm; week 24, BA: 35.42 +/- 6.16 mmol kg(-1) dm, PL: 31.99 +/- 5.60 mmol kg(-1) dm). There was no effect of treatment, time or any interaction effects on any blood marker (all p > 0.05) and no self-reported side-effects in these participants throughout the study. Conclusions The current study showed that 24 weeks of BA supplementation at 6.4 g day(-1) did not significantly affect muscle taurine content, clinical markers of renal, hepatic and muscle function, nor did it result in chronic sensory side-effects, in healthy individuals. Since athletes are likely to engage in chronic supplementation, these data provide important evidence to suggest that supplementation with BA at these doses for up to 24 weeks is safe for healthy individuals. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/50438-0, 2017/04973-4, 2015/22686-7, 2013/04806-0, 2012/13026-5, 2014/11948-8, 2013/14746-4] | |
dc.description.sponsorship | Coordenacao de Aper-feicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001] | |
dc.description.sponsorship | National Alternatives International (NAI), San Marcos, California | |
dc.identifier.citation | EUROPEAN JOURNAL OF NUTRITION, v.59, n.1, p.57-65, 2020 | |
dc.identifier.doi | 10.1007/s00394-018-1881-0 | |
dc.identifier.eissn | 1436-6215 | |
dc.identifier.issn | 1436-6207 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/35575 | |
dc.language.iso | eng | |
dc.publisher | SPRINGER HEIDELBERG | eng |
dc.relation.ispartof | European Journal of Nutrition | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright SPRINGER HEIDELBERG | eng |
dc.subject | Chronic beta-alanine supplementation | eng |
dc.subject | Muscle taurine | eng |
dc.subject | Clinical markers | eng |
dc.subject | Safety | eng |
dc.subject | Side-effects | eng |
dc.subject.other | skeletal-muscle | eng |
dc.subject.other | carnosine content | eng |
dc.subject.other | individual fibers | eng |
dc.subject.other | elderly subjects | eng |
dc.subject.other | supplementation | eng |
dc.subject.other | performance | eng |
dc.subject.other | exercise | eng |
dc.subject.other | histidine | eng |
dc.subject.other | capacity | eng |
dc.subject.other | anserine | eng |
dc.subject.wos | Nutrition & Dietetics | eng |
dc.title | 24-Week beta-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy males | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Inglaterra | |
hcfmusp.affiliation.countryiso | gb | |
hcfmusp.author.external | FRANCHI, Mariana:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil | |
hcfmusp.author.external | SILVA, Vinicius da Eira:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil | |
hcfmusp.author.external | PAINELLI, Vitor de Salles:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil | |
hcfmusp.author.external | COSTA, Luiz Augusto Riani:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil | |
hcfmusp.author.external | SALE, Craig:Nottingham Trent Univ, Musculoskeletal Physiol Res Grp, Sport Hlth & Performance Enhancement Res Ctr, Nottingham, England | |
hcfmusp.author.external | HARRIS, Roger Charles:Junipa Ltd, Newmarket, Suffolk, England | |
hcfmusp.citation.scopus | 13 | |
hcfmusp.contributor.author-fmusphc | BRYAN SAUNDERS | |
hcfmusp.contributor.author-fmusphc | LUANA FARIAS DE OLIVEIRA | |
hcfmusp.contributor.author-fmusphc | RAFAEL PIRES DA SILVA | |
hcfmusp.contributor.author-fmusphc | HAMILTON AUGUSTO ROSCHEL DA SILVA | |
hcfmusp.contributor.author-fmusphc | GUILHERME GIANNINI ARTIOLI | |
hcfmusp.contributor.author-fmusphc | BRUNO GUALANO | |
hcfmusp.description.beginpage | 57 | |
hcfmusp.description.endpage | 65 | |
hcfmusp.description.issue | 1 | |
hcfmusp.description.volume | 59 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 30552505 | |
hcfmusp.origem.scopus | 2-s2.0-85058392528 | |
hcfmusp.origem.wos | WOS:000512078900005 | |
hcfmusp.publisher.city | HEIDELBERG | eng |
hcfmusp.publisher.country | GERMANY | eng |
hcfmusp.relation.reference | BAKARDJIEV A, 1994, EUR J BIOCHEM, V225, P617, DOI 10.1111/j.1432-1033.1994.00617.x | eng |
hcfmusp.relation.reference | BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787 | eng |
hcfmusp.relation.reference | Blancquaert L, 2017, MED SCI SPORT EXER, V49, P602, DOI 10.1249/MSS.0000000000001213 | eng |
hcfmusp.relation.reference | Blancquaert L, 2016, J PHYSIOL-LONDON, V594, P4849, DOI 10.1113/JP272050 | eng |
hcfmusp.relation.reference | Church DD, 2017, J AM COLL NUTR, V36, P608, DOI 10.1080/07315724.2017.1335250 | eng |
hcfmusp.relation.reference | Crozier RA, 2007, J NEUROSCI, V27, P4492, DOI 10.1523/JNEUROSCI.4932-06.2007 | eng |
hcfmusp.relation.reference | Dawson R, 2002, AMINO ACIDS, V22, P309 | eng |
hcfmusp.relation.reference | Decombaz J, 2012, AMINO ACIDS, V43, P67, DOI 10.1007/s00726-011-1169-7 | eng |
hcfmusp.relation.reference | del Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-x | eng |
hcfmusp.relation.reference | Dunnett M, 1997, RES VET SCI, V62, P213, DOI 10.1016/S0034-5288(97)90192-2 | eng |
hcfmusp.relation.reference | Dunnett M, 1997, J CHROMATOGR B, V688, P47, DOI 10.1016/S0378-4347(97)88054-1 | eng |
hcfmusp.relation.reference | Everaert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4 | eng |
hcfmusp.relation.reference | Everaert I, 2013, MED SCI SPORT EXER, V45, P43, DOI 10.1249/MSS.0b013e31826cdb68 | eng |
hcfmusp.relation.reference | Galloway SDR, 2008, J APPL PHYSIOL, V105, P643, DOI 10.1152/japplphysiol.90525.2008 | eng |
hcfmusp.relation.reference | Hamilton EJ, 2006, AMINO ACIDS, V31, P273, DOI 10.1007/s00726-006-0291-4 | eng |
hcfmusp.relation.reference | Harris RC, 1998, J SPORT SCI, V16, P639 | eng |
hcfmusp.relation.reference | Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9 | eng |
hcfmusp.relation.reference | Harris RC, 2010, MED SCI SPORT EXER, V42, P107, DOI 10.1249/01.MSS.0000385977.18201.74 | eng |
hcfmusp.relation.reference | Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4 | eng |
hcfmusp.relation.reference | Hobson RM, 2012, MED SCI SPORT EXER, V44, P446 | eng |
hcfmusp.relation.reference | Ito T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107409 | eng |
hcfmusp.relation.reference | Kelly VG, 2017, J SCI MED SPORT, V20, P12, DOI 10.1016/j.jsams.2016.06.006 | eng |
hcfmusp.relation.reference | Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027 | eng |
hcfmusp.relation.reference | Neves M, 2012, SCAND J MED SCI SPOR, V22, P175, DOI 10.1111/j.1600-0838.2010.01264.x | eng |
hcfmusp.relation.reference | Ripps H, 2012, MOL VIS, V18, P2673 | eng |
hcfmusp.relation.reference | Saunders B, 2017, MED SCI SPORT EXER, V49, P896, DOI 10.1249/MSS.0000000000001173 | eng |
hcfmusp.relation.reference | Saunders B, 2017, BRIT J SPORT MED, V51, P658, DOI 10.1136/bjsports-2016-096396 | eng |
hcfmusp.relation.reference | Saunders B, 2013, J SCI MED SPORT, V16, P286, DOI 10.1016/j.jsams.2012.07.004 | eng |
hcfmusp.relation.reference | Schaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2 | eng |
hcfmusp.relation.reference | Stellingwerff T, 2012, AMINO ACIDS, V42, P2461, DOI 10.1007/s00726-011-1054-4 | eng |
hcfmusp.relation.reference | Tallon MJ, 2007, BIOGERONTOLOGY, V8, P129, DOI 10.1007/s10522-006-9038-6 | eng |
hcfmusp.relation.reference | Varanoske AN, 2019, AMINO ACIDS, V51, P49, DOI 10.1007/s00726-018-2609-4 | eng |
hcfmusp.relation.reference | Varanoske AN, 2017, NUTR RES, V48, P16, DOI 10.1016/j.nutres.2017.10.002 | eng |
hcfmusp.relation.reference | Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | 39afd5be-de53-43b7-bc2f-24532eec0e43 | |
relation.isAuthorOfPublication | 4ebc76f6-ffc8-4e43-81a1-a85cc60c561b | |
relation.isAuthorOfPublication | ae931d3d-9e35-450b-84cd-b87d5176838a | |
relation.isAuthorOfPublication | b7438df7-d183-4a0f-a97f-2d70d38200af | |
relation.isAuthorOfPublication | 833cdd9d-bcf7-4352-b10d-d04ff8717cd0 | |
relation.isAuthorOfPublication | 5c94f430-a9d0-4b0e-b23a-9a9b1fc12a9a | |
relation.isAuthorOfPublication.latestForDiscovery | 39afd5be-de53-43b7-bc2f-24532eec0e43 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_SAUNDERS_24Week_betaalanine_ingestion_does_not_affect_muscle_taurine_2020.PDF.pdf
- Tamanho:
- 806.17 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)